Starling OncologySTLN

13F holders, Q2 2024 (June 30)
39holders −8
4new positions
12sold out
3famous investors
$0.47avg. 13F price*

At the end of Q2 2024, 39 institutions reported holding Starling Oncology Inc. (STLN) in their 13F filings, down 8 from Q1 2024. 4 opened new positions and 12 sold out. The largest holders were FMR LLC ($2.2M), Deerfield Management Company, L.P. ($1.5M) and Vanguard Group Inc. ($820K). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).

Company
Starling Oncology Inc.
Filed as
THE ONCOLOGY INSTITUTE INC (Q2 2024)
CUSIP
68236X100
Latest filing quarter
Q2 2026

History

Number of 13F holders

050100150 Q1 2024: 47Q1 2024Q2 2024: 39Q2 2024Q3 2024: 34Q3 2024Q4 2024: 31Q4 2024Q1 2025: 43Q1 2025Q2 2025: 79Q2 2025Q3 2025: 108Q3 2025Q4 2025: 117Q4 2025Q1 2026: 115Q1 2026Q2 2026: 119Q2 2026

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions4$42K
Exits12$1.1M

All 13F filers, Q1 2024 → Q2 2024: 2,158,863 shares bought and 713,993 shares sold, net +1,444,870 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 39 holders

FMR LLC 0.00% Reduce -0.1% 4,751,389 $2.2M
Deerfield Management Company, L.P. 0.03% No change 3,360,052 $1.5M
Vanguard Group Inc. 0.00% No change 1,783,454 $820K
Kent Lake Capital LLC 0.36% Add +47.5% 1,750,000 $805K
Balyasny Asset Management L.P. 0.00% No change 1,725,562 $794K
Tiff Advisory Services, LLC 0.23% Add +235.1% 1,418,685 $653K
Triatomic Management LP 10.90% Reduce -9.2% 802,965 $369K
Cincinnati Insurance Co. 0.01% No change 699,500 $322K
Boston Financial Mangement LLC 0.01% Reduce -62.4% 2,767 $231K
Geode Capital Management, LLC 0.00% Add +1.7% 360,264 $166K
Renaissance Technologies 0.00% Add +142.3% 339,400 $156K
Citadel Advisors 0.00% Add +794.7% 269,704 $124K
FourWorld Capital Management LLC 0.16% Add +2.6% 257,000 $118K
BlackRock Inc. 0.00% Add +37.1% 204,814 $94K
FreeGulliver LLC 0.06% No change 188,169 $87K
Millennium Management 0.00% Reduce -26.3% 109,207 $50K
State Street Corp. 0.00% No change 101,300 $47K
Saba Capital Management, L.P. 0.00% No change 94,264 $43K
Fielder Capital Group LLC 0.01% No change 70,192 $32K
Northern Trust Corp. 0.00% Reduce -0.1% 64,902 $30K
Quattro Financial Advisors LLC 0.01% No change 55,960 $26K
Bank of New York Mellon Corp 0.00% No change 45,068 $21K
Jane Street Group, LLC 0.00% New 31,611 $15K
Susquehanna International Group, LLP 0.00% New 31,182 $14K
Morgan Stanley 0.00% Reduce -58.4% 29,340 $13K
HighTower Advisors, LLC 0.00% No change 27,980 $13K
Lee Financial Co 0.00% No change 27,980 $13K
Cresset Asset Management, LLC 0.00% New 18,300 $8K
Vanguard Personalized Indexing Management, LLC 0.00% Reduce -5.1% 17,984 $8K
Qube Research & Technologies Ltd 0.00% Reduce -49.6% 15,642 $7K
XTX Topco Ltd 0.00% Reduce -58.4% 11,457 $5K
Mariner, LLC 0.00% Reduce -40.5% 10,884 $5K
AMG National Trust Bank 0.00% New 10,000 $5K
Tower Research Capital LLC (TRC) 0.00% Add +26.8% 9,832 $5K
Bank of America Corp. 0.00% Reduce -31.6% 2,671 $1K
Rhumbline Advisers 0.00% No change 2,175 $1K
JPMorgan Chase & Co. 0.00% Reduce -98.1% 170 $78
Citigroup Inc. 0.00% Reduce -99.7% 40 $18
Royal Bank of Canada 0.00% Add +136.4% 130 $0

"% of holder's portfolio" is STLN's weight in each manager's 13F, not the share of Starling Oncology Inc. the manager owns.